Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
That same month, the FTC published a report describing PBMs as powerful middlemen who “may be profiting by inflating drug ...
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "This action continues a troubling pattern ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...
The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback